Literature DB >> 33875229

The Importance of Apparent pKa in the Development of Nanoparticles Encapsulating siRNA and mRNA.

Pratikkumar Patel1, Nurudeen Mohammed Ibrahim1, Kun Cheng2.   

Abstract

Polymer and lipid nanoparticles have been extensively used as carriers to address the biological barriers encountered in siRNA and mRNA delivery. We summarize the crucial role of nanoparticle charge and ionizability in complexing RNAs, binding to biological components, escaping from the endosome, and releasing RNAs into the cytoplasm. We highlight the significant impact of the apparent pKa of nanoparticles on their efficacy and toxicity, and the importance of optimizing pKa in the development of lead formulations for RNAs. We also discuss the feasibility of fine-tuning the pKa in nanoparticles and the applications of this approach in the optimization of delivery systems for RNAs.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  RNA delivery; endosomal escape; lipid; nanoparticles; pKa; polymer; vaccine

Mesh:

Substances:

Year:  2021        PMID: 33875229      PMCID: PMC8148296          DOI: 10.1016/j.tips.2021.03.002

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   17.638


  83 in total

1.  Biological and therapeutic applications of small RNAs.

Authors:  Kun Cheng; Ram I Mahato
Journal:  Pharm Res       Date:  2011-10-28       Impact factor: 4.200

2.  How and why nanoparticle's curvature regulates the apparent pKa of the coating ligands.

Authors:  Dawei Wang; Rikkert J Nap; István Lagzi; Bartlomiej Kowalczyk; Shuangbing Han; Bartosz A Grzybowski; Igal Szleifer
Journal:  J Am Chem Soc       Date:  2011-01-31       Impact factor: 15.419

3.  Characterisation of selected active agents regarding pKa values, solubility concentrations and pH profiles by SiriusT3.

Authors:  D Schönherr; U Wollatz; D Haznar-Garbacz; U Hanke; K J Box; R Taylor; R Ruiz; S Beato; D Becker; W Weitschies
Journal:  Eur J Pharm Biopharm       Date:  2015-03-07       Impact factor: 5.571

4.  Efficiency of Chitosan/Hyaluronan-Based mRNA Delivery Systems In Vitro: Influence of Composition and Structure.

Authors:  Ousamah Younoss Soliman; Mohamad Gabriel Alameh; Gregory De Cresenzo; Michael D Buschmann; Marc Lavertu
Journal:  J Pharm Sci       Date:  2019-12-28       Impact factor: 3.534

5.  Ionizable amino lipid interactions with POPC: implications for lipid nanoparticle function.

Authors:  M Ramezanpour; M L Schmidt; I Bodnariuc; J A Kulkarni; S S W Leung; P R Cullis; J L Thewalt; D P Tieleman
Journal:  Nanoscale       Date:  2019-08-01       Impact factor: 7.790

6.  Relationship Between the Physicochemical Properties of Lipid Nanoparticles and the Quality of siRNA Delivery to Liver Cells.

Authors:  Yusuke Sato; Hiroto Hatakeyama; Mamoru Hyodo; Hideyoshi Harashima
Journal:  Mol Ther       Date:  2015-12-18       Impact factor: 11.454

7.  Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering.

Authors:  Margaret M Billingsley; Nathan Singh; Pranali Ravikumar; Rui Zhang; Carl H June; Michael J Mitchell
Journal:  Nano Lett       Date:  2020-02-05       Impact factor: 11.189

8.  Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling.

Authors:  Gaurav Sahay; William Querbes; Christopher Alabi; Ahmed Eltoukhy; Sovan Sarkar; Christopher Zurenko; Emmanouil Karagiannis; Kevin Love; Delai Chen; Roberto Zoncu; Yosef Buganim; Avi Schroeder; Robert Langer; Daniel G Anderson
Journal:  Nat Biotechnol       Date:  2013-06-23       Impact factor: 54.908

Review 9.  Advances in the delivery of RNA therapeutics: from concept to clinical reality.

Authors:  James C Kaczmarek; Piotr S Kowalski; Daniel G Anderson
Journal:  Genome Med       Date:  2017-06-27       Impact factor: 11.117

Review 10.  Opportunities and Challenges in the Delivery of mRNA-based Vaccines.

Authors:  Abishek Wadhwa; Anas Aljabbari; Abhijeet Lokras; Camilla Foged; Aneesh Thakur
Journal:  Pharmaceutics       Date:  2020-01-28       Impact factor: 6.321

View more
  10 in total

1.  Amphiphilic Dendrimer Vectors for RNA Delivery: State-of-the-Art and Future Perspective.

Authors:  Jiaxuan Chen; Dandan Zhu; Xiaoxuan Liu; Ling Peng
Journal:  Acc Mater Res       Date:  2022-05-03

Review 2.  Tailoring combinatorial lipid nanoparticles for intracellular delivery of nucleic acids, proteins, and drugs.

Authors:  Yamin Li; Zhongfeng Ye; Hanyi Yang; Qiaobing Xu
Journal:  Acta Pharm Sin B       Date:  2022-04-27       Impact factor: 14.903

Review 3.  The role of lipid components in lipid nanoparticles for vaccines and gene therapy.

Authors:  Camilla Hald Albertsen; Jayesh A Kulkarni; Dominik Witzigmann; Marianne Lind; Karsten Petersson; Jens B Simonsen
Journal:  Adv Drug Deliv Rev       Date:  2022-07-03       Impact factor: 17.873

Review 4.  Inhalable mRNA vaccines for respiratory diseases: a roadmap.

Authors:  Esther H Roh; Catherine A Fromen; Millicent O Sullivan
Journal:  Curr Opin Biotechnol       Date:  2021-12-08       Impact factor: 10.279

5.  Thermostable ionizable lipid-like nanoparticle (iLAND) for RNAi treatment of hyperlipidemia.

Authors:  Bo Hu; Bo Li; Kun Li; Yuanyuan Liu; Chunhui Li; Lulu Zheng; Mengjie Zhang; Tongren Yang; Shuai Guo; Xiyu Dong; Tian Zhang; Qing Liu; Abid Hussain; Yuhua Weng; Ling Peng; Yongxiang Zhao; Xing-Jie Liang; Yuanyu Huang
Journal:  Sci Adv       Date:  2022-02-16       Impact factor: 14.136

6.  Chitosan Oleate Coated PLGA Nanoparticles as siRNA Drug Delivery System.

Authors:  Dalila Miele; Xin Xia; Laura Catenacci; Milena Sorrenti; Silvia Rossi; Giuseppina Sandri; Franca Ferrari; John J Rossi; Maria Cristina Bonferoni
Journal:  Pharmaceutics       Date:  2021-10-17       Impact factor: 6.525

Review 7.  RNA-based therapeutics: an overview and prospectus.

Authors:  Yiran Zhu; Liyuan Zhu; Xian Wang; Hongchuan Jin
Journal:  Cell Death Dis       Date:  2022-07-23       Impact factor: 9.685

Review 8.  Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics.

Authors:  Hidefumi Mukai; Koki Ogawa; Naoya Kato; Shigeru Kawakami
Journal:  Drug Metab Pharmacokinet       Date:  2022-02-05       Impact factor: 2.041

Review 9.  Nanocarriers for delivery of siRNA as gene silencing mediator.

Authors:  Aideé Morales-Becerril; Liliana Aranda-Lara; Keila Isaac-Olivé; Blanca E Ocampo-García; Enrique Morales-Ávila
Journal:  EXCLI J       Date:  2022-08-01       Impact factor: 4.022

10.  Impact of Formulation Conditions on Lipid Nanoparticle Characteristics and Functional Delivery of CRISPR RNP for Gene Knock-Out and Correction.

Authors:  Johanna Walther; Danny Wilbie; Vincent S J Tissingh; Mert Öktem; Heleen van der Veen; Bo Lou; Enrico Mastrobattista
Journal:  Pharmaceutics       Date:  2022-01-17       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.